Advanced search
Publication Cover
OncoTargets and Therapy Volume 14, 2021 - Issue
Submit an article Journal homepage
127
Views
13
CrossRef citations to date
0
Altmetric
Original Research

A Novel Biological Activity of the STAT3 Inhibitor Stattic in Inhibiting Glutathione Reductase and Suppressing the Tumorigenicity of Human Cervical Cancer Cells via a ROS-Dependent Pathway

Yuchen Xia1 Graduate School, Hunan University of Chinese Medicine, Changsha, Hunan, People’s Republic of China;2 Department of Oncology, Changsha Central Hospital, University of South China, Changsha, Hunan, People’s Republic of China
,
Guihua Wang2 Department of Oncology, Changsha Central Hospital, University of South China, Changsha, Hunan, People’s Republic of ChinaCorrespondence[email protected]
,
Manli Jiang3 Medical Research Center, Changsha Central Hospital, University of South China, Changsha, Hunan, People’s Republic of China
,
Xueting Liu3 Medical Research Center, Changsha Central Hospital, University of South China, Changsha, Hunan, People’s Republic of China
,
Yan Zhao4 Department of Pathology, Changsha Central Hospital, University of South China, Changsha, Hunan, People’s Republic of China
,
Yinghui Song5 Department of Hepatobiliary Surgery, Hunan Provincial People’s Hospital, Hunan Normal University, Changsha, Hunan, People’s Republic of China
,
Binyuan Jiang3 Medical Research Center, Changsha Central Hospital, University of South China, Changsha, Hunan, People’s Republic of China
,
Demao Zhu4 Department of Pathology, Changsha Central Hospital, University of South China, Changsha, Hunan, People’s Republic of China
,
Ling Hu6 Department of Clinical Laboratory, Changsha Central Hospital, University of South China, Changsha, Hunan, People’s Republic of China
,
Zhao Zhang6 Department of Clinical Laboratory, Changsha Central Hospital, University of South China, Changsha, Hunan, People’s Republic of China
,
Ting Cao6 Department of Clinical Laboratory, Changsha Central Hospital, University of South China, Changsha, Hunan, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-6554-6886
ORCID Icon,
Ji Ming Wang7 Laboratory of Cancer Immunometabolism, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD, 21702, USA
&
Jinyue Hu3 Medical Research Center, Changsha Central Hospital, University of South China, Changsha, Hunan, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7709-3127
ORCID Icon show all
Pages 4047-4060 | Published online: 05 Jul 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.